SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFR14A - Revised definitive proxy soliciting materials:
SEC Accession No. 0001144204-19-026869
Filing Date
2019-05-16
Accepted
2019-05-16 17:00:40
Documents
13
Effectiveness Date
2019-05-16

Document Format Files

Seq Description Document Type Size
1 DEFR14A tv521352_defr14a.htm DEFR14A 664970
2 GRAPHIC tv521352_img01.jpg GRAPHIC 5417
3 GRAPHIC tv521352_img02.jpg GRAPHIC 157018
4 GRAPHIC tv521352_img03.jpg GRAPHIC 240522
5 GRAPHIC tv521352_img04.jpg GRAPHIC 70411
6 GRAPHIC tv521352_img05.jpg GRAPHIC 13654
7 GRAPHIC tv521352_img06.jpg GRAPHIC 100355
8 GRAPHIC tv521352_img07.jpg GRAPHIC 125008
9 GRAPHIC tv521352_img08.jpg GRAPHIC 196949
10 GRAPHIC tv521352_img09.jpg GRAPHIC 223709
11 GRAPHIC tv521352_img10.jpg GRAPHIC 95312
12 GRAPHIC tv521352_img11.jpg GRAPHIC 305940
13 GRAPHIC tv521352_img12.jpg GRAPHIC 201435
  Complete submission text file 0001144204-19-026869.txt   3027821
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFR14A | Act: 34 | File No.: 001-37977 | Film No.: 19833130
SIC: 2834 Pharmaceutical Preparations